These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 22499046

  • 1. [Retrospective analysis of progression to multiple myeloma or related disorders in 114 patients with monoclonal gammopathy of undetermined significance in a single institute].
    Yokota S, Urasaki Y, Nakamura Y, Bessho M.
    Rinsho Ketsueki; 2012 Mar; 53(3):303-9. PubMed ID: 22499046
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Mar; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 3. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.
    Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
    [Abstract] [Full Text] [Related]

  • 4. [Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients].
    Salgado C, Bladé J, López-Guillermo A, Cervantes F, Montserrat E, Rozman C.
    Sangre (Barc); 1993 Oct; 38(5):371-4. PubMed ID: 8140498
    [Abstract] [Full Text] [Related]

  • 5. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A, Czarkowska-Paczek B.
    Przegl Lek; 2012 Oct; 69(5):194-6. PubMed ID: 23050415
    [Abstract] [Full Text] [Related]

  • 6. Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
    Za T, De Stefano V, Rossi E, Petrucci MT, Andriani A, Annino L, Cimino G, Caravita T, Pisani F, Ciminello A, Torelli F, Villivà N, Bongarzoni V, Rago A, Betti S, Levi A, Felici S, Gentilini F, Calabrese E, Leone G, Multiple Myeloma GIMEMA-Latium Region Working Group.
    Br J Haematol; 2013 Mar; 160(5):673-9. PubMed ID: 23240810
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA, Rajkumar SV.
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [Abstract] [Full Text] [Related]

  • 8. Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
    Bladé J, Rosiñol L, Cibeira MT, de Larrea CF.
    Leukemia; 2008 Sep; 22(9):1651-7. PubMed ID: 18668131
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
    Cabrera Q, Macro M, Hebert B, Cornet E, Collignon A, Troussard X.
    Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
    [Abstract] [Full Text] [Related]

  • 10. [Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].
    Ruiz-Delgado GJ, Gómez Rangel JD.
    Gac Med Mex; 2004 Aug; 140(4):375-9. PubMed ID: 15456147
    [Abstract] [Full Text] [Related]

  • 11. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
    Chang SH, Luo S, O'Brian KK, Thomas TS, Colditz GA, Carlsson NP, Carson KR.
    Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
    [Abstract] [Full Text] [Related]

  • 12. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE, Turesson I, Lund SH, Lindqvist EK, Mailankody S, Korde N, Björkholm M, Landgren O, Kristinsson SY.
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, Rajkumar SV.
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
    [Abstract] [Full Text] [Related]

  • 14. Fracture risk in monoclonal gammopathy of undetermined significance.
    Melton LJ, Rajkumar SV, Khosla S, Achenbach SJ, Oberg AL, Kyle RA.
    J Bone Miner Res; 2004 Jan; 19(1):25-30. PubMed ID: 14753733
    [Abstract] [Full Text] [Related]

  • 15. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
    Zou D, An G, Zhu G, Wang J, Shi L, Meng H, Xu Y, Sui W, Deng S, Zhan F, Qiu L.
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
    [Abstract] [Full Text] [Related]

  • 16. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS, Gundrum JD, Neuner JM.
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [Abstract] [Full Text] [Related]

  • 17. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.
    Jerez A, Ortuño FJ, Osma Mdel M, Español I, González AD, Roldán V, de Arriba F, Vicente V.
    Ann Med; 2009 Mar; 41(7):547-58. PubMed ID: 19634064
    [Abstract] [Full Text] [Related]

  • 18. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ.
    N Engl J Med; 2002 Feb 21; 346(8):564-9. PubMed ID: 11856795
    [Abstract] [Full Text] [Related]

  • 19. Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study.
    Chang SH, Luo S, Thomas TS, O'Brian KK, Colditz GA, Carlsson NP, Carson KR.
    J Natl Cancer Inst; 2017 May 21; 109(5):. PubMed ID: 28040690
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.
    Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK.
    Transplantation; 2011 Sep 15; 92(5):570-4. PubMed ID: 21712755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.